Argus Investors Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$2.02M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$1.39M |
| 3 |
McKesson
MCK
|
+$1.2M |
| 4 |
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
|
+$955K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.57M |
| 2 |
Archer Daniels Midland
ADM
|
+$1.47M |
| 3 |
Union Pacific
UNP
|
+$1.43M |
| 4 |
PayPal
PYPL
|
+$1.18M |
| 5 |
Broadcom
AVGO
|
+$865K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.38% |
| 2 | Financials | 15.18% |
| 3 | Healthcare | 14.94% |
| 4 | Industrials | 13% |
| 5 | Consumer Discretionary | 8.5% |
Similar funds
Argus Investors Counsel's Q1 2024 Portfolio in Review
As of Q1 2024, Argus Investors Counsel held 114 positions worth $163M, up 4.6% from $156M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Argus Investors Counsel withdrew a net $8.97M in Q1 2024, closing 6 positions and reducing 66 holdings. Its most notable exit was Archer Daniels Midland, an estimated $1.47M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Argus Investors Counsel opened a new position in Regeneron Pharmaceuticals worth $1.41M.
- Argus Investors Counsel's largest Q1 2024 buy was Regeneron Pharmaceuticals: 1,465 shares worth $1.41M.
- Argus Investors Counsel added most to Trane Technologies in Q1 2024, an estimated $2.02M increase.
- Argus Investors Counsel's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $3.57M.
- Argus Investors Counsel fully exited Archer Daniels Midland in Q1 2024, selling an estimated $1.47M.
- Argus Investors Counsel's ten largest holdings make up 28% of its $163M portfolio in Q1 2024.
- Argus Investors Counsel opened 16 new positions and closed 6 in Q1 2024.
- Argus Investors Counsel's portfolio value rose 4.6% quarter-over-quarter to $163M.
Based on Argus Investors Counsel's 13F filing for Q1 2024, filed 25 Apr 2024.